George N Karanikolas

Suggest Changes
Learn More
OBJECTIVE To assess the efficacy and safety of adalimumab or cyclosporine (CYC) as monotherapy or combination therapy for patients with active psoriatic arthritis (PsA), despite methotrexate (MTX)(More)
OBJECTIVE To assess the efficacy and safety of anakinra (ANK) as an add-on therapy in RA patients with inadequate response to monotherapy with non-biological DMARDs. METHODS A 48-week comparative,(More)
  • 1